|
RBM15B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.01299999999361E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.410300E-02 |
| Normal-vs-Stage2 |
2.42309999998191E-06 |
| Normal-vs-Stage3 |
9.88069626117749E-11 |
| Normal-vs-Stage4 |
1.54330999999619E-05 |
| Stage1-vs-Stage2 |
4.802000E-04 |
| Stage1-vs-Stage3 |
2.61520000099935E-08 |
| Stage1-vs-Stage4 |
1.303230E-03 |
| Stage2-vs-Stage3 |
6.340000E-01 |
| Stage2-vs-Stage4 |
6.314400E-01 |
| Stage3-vs-Stage4 |
2.740600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08899999995415E-06 |
| Normal-vs-AfricanAmerican |
9.399200E-01 |
| Normal-vs-Asian |
4.481000E-01 |
| Caucasian-vs-AfricanAmerican |
2.098500E-03 |
| Caucasian-vs-Asian |
3.463000E-01 |
| AfricanAmerican-vs-Asian |
5.802600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.70090000004308E-06 |
| Normal-vs-Female |
4.219700E-03 |
| Male-vs-Female |
1.065190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.796600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.191210E-04 |
| Normal-vs-Age(61-80Yrs) |
9.91270000000322E-05 |
| Normal-vs-Age(81-100Yrs) |
1.53608999999832E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.245850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.022980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.143800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.263000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.747900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.609600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.673760E-01 |
| Normal-vs-Grade 2 |
2.569500E-02 |
| Normal-vs-Grade 3 |
1.44709999538861E-09 |
| Normal-vs-Grade 4 |
3.65869999999768E-05 |
| Grade 1-vs-Grade 2 |
2.122100E-02 |
| Grade 1-vs-Grade 3 |
2.57280000004467E-06 |
| Grade 1-vs-Grade 4 |
3.759400E-04 |
| Grade 2-vs-Grade 3 |
2.11359999999772E-05 |
| Grade 2-vs-Grade 4 |
2.014300E-02 |
| Grade 3-vs-Grade 4 |
5.383600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.5231000000403E-06 |
| Normal-vs-ccB subtype |
1.039290E-03 |
| ccA subtype-vs-ccB subtype |
4.879000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84040000001029E-06 |
| Normal-vs-N1 |
5.099300E-03 |
| N0-vs-N1 |
6.161000E-01 |
|
|
